MedTrace Logo

The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder

NCT05986552 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2026-05-06

No results posted yet for this study

Summary

The goal of this clinical trial is to compare etc. in patients with borderline personality disorder pure individual schema therapy to combined individual-group schema therapy. The main questions it aims to answer are:

* is there a difference in effectiveness?
* is there a difference in (early) treatment dropout?

Participants will receive either

* individual schema therapy or
* combined individual-group schema therapy.

Researchers will compare individual to combined individual-group schema therapy see if there is a difference in effects and/or a difference in dropout from treatment.

Conditions

  • Borderline Personality Disorder

Interventions

BEHAVIORAL

Individual Schema Therapy (IST)

IST is a form of empirically supported specialized psychotherapy for personality disorders. It is delivered in individual sessions by trained therapists.

BEHAVIORAL

Individual-Group Schema Therapy (IGST)

IGST is a form of empirically supported specialized psychotherapy for personality disorders. It is delivered in the combination of individual sessions and group therapy sessions by trained therapists.

Sponsors & Collaborators

  • Academic Center for Trauma and Personality

    collaborator UNKNOWN

  • Arkin Mental Health Care

    collaborator UNKNOWN

  • Ggz Oost Brabant

    collaborator OTHER

  • University of Amsterdam

    lead OTHER

Principal Investigators

  • Arnoud Arntz, PhD · University of Amsterdam

  • Sophie Rameckers, MSc · University of Amsterdam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2030-08-30
Completion
2030-08-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986552 on ClinicalTrials.gov